Nyxoah Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St · 08/20/2025 04:44
ENXTBR:NYXH 1 Year Share Price vs Fair Value
ENXTBR:NYXH 1 Year Share Price vs Fair Value
Explore Nyxoah's Fair Values from the Community and select yours

Nyxoah (EBR:NYXH) Second Quarter 2025 Results

Key Financial Results

  • Net loss: €20.6m (loss widened by 57% from 2Q 2024).
  • €0.55 loss per share (further deteriorated from €0.43 loss in 2Q 2024).
earnings-and-revenue-history
ENXTBR:NYXH Earnings and Revenue History August 20th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Nyxoah EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 8.5%. Earnings per share (EPS) exceeded analyst estimates by 3.3%.

Looking ahead, revenue is forecast to grow 53% p.a. on average during the next 3 years, compared to a 7.1% growth forecast for the Medical Equipment industry in Europe.

Performance of the market in Belgium.

The company's shares are down 11% from a week ago.

Risk Analysis

You still need to take note of risks, for example - Nyxoah has 3 warning signs (and 2 which shouldn't be ignored) we think you should know about.